Evidence map›Paper›PMID 29273937›Full record

ArticleRheumatology international2018

Correction to: Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety.

Milena A Gianfrancesco, Gabriela Schmajuk, Sarah Haserodt, Laura Trupin, Zara Izadi, Kashif Jafri, Stephen Shiboski, Marina Sirota, R Adams Dudley, Jinoos Yazdany

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 73% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Milena A GianfrancescoDivision of Rheumatology, University of California, San Francisco, 513 Parnassus Avenue, San Francisco, CA, 94143, USA. Milena.Gianfrancesco@ucsf.edu.ORCID 0000-0002-8351-4626
Gabriela SchmajukDivision of Rheumatology, University of California, San Francisco, 513 Parnassus Avenue, San Francisco, CA, 94143, USA.
Sarah HaserodtDepartment of Medicine, California Pacific Medical Center, San Francisco, USA.
Laura TrupinDivision of Rheumatology, University of California, San Francisco, 513 Parnassus Avenue, San Francisco, CA, 94143, USA.
Zara IzadiDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, USA.
Kashif JafriDivision of Rheumatology, University of California, San Francisco, 513 Parnassus Avenue, San Francisco, CA, 94143, USA.
Stephen ShiboskiDepartment of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, USA.
Marina SirotaInstitute for Computational Health Sciences, University of California, San Francisco, San Francisco, USA.
R Adams DudleyCenter for Healthcare Value, Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco, USA.
Jinoos YazdanyDivision of Rheumatology, University of California, San Francisco, 513 Parnassus Avenue, San Francisco, CA, 94143, USA.
University of California, San Francisco · USCalifornia Pacific Medical Center · USLee University · USSan Francisco VA Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The given and family name of a co-author R. Adams Dudley was swapped in the published article. The correct given name is R. Adams and the family name is Dudley.

Identifiers

PMID29273937
OpenAlexW2776422205

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.